Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Hasegawa K, Shimada M, Takeuchi S, Fujiwara H, et al. A phase 2 study of intraperitoneal carboplatin plus intravenous dose-dense paclitaxel in front-line treatment of suboptimal residual ovarian cancer. Br J Cancer 2020 Jan 31. pii: 10.1038/s41416-020-0734.
PMID: 32001833


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016